Males with lupus nephritis had higher all-cause mortality and proportion of infection-related death compared to females.

There are no significant differences in outcomes post-AMI in patients with systemic lupus erythematosus vs the general population.

Immune cells called monocytes produce a key inflammatory protein called interleukin-1 beta (IL-1β) through an unconventional pathway in patients with systemic lupus erythematosus, commonly referred to ...

Analyst Julian Harrison of BTIG maintained a Buy rating on Cullinan Management (CGEM – Research Report), retaining the price target of ...

Clinical stage biopharma Kezar Life Sciences is discontinuing its lupus nephritis (LN) clinical programme following the death ...

Cambridge, Massachusetts Thursday, October 17, 2024, 17:00 Hrs [IST] ...

A new study suggests that your morning cup of coffee might do more than just wake you up – it could be giving your blood ...

Monitoring and supplementing maternal 25(OH) vitamin D levels in patients with lupus within the 40-59 ng/mL range are crucial while preventing excessive supplementation, this study suggested.

HC Wainwright has initiated coverage on Alumis Inc. (NASDAQ:ALMS), a clinical-stage biopharmaceutical company developing oral ...

Completes Transition to Immune-Mediated Disease Focused CompanyHighlights Additional Data from Phase 1b Primary Membranous ...

ImmuneSensor begins patient dosing in phase 1 trial of lead cGAS inhibitor drug candidate, IMSB301 to treat inflammatory and autoimmune diseases: Dallas, Texas Thursday, October 1 ...

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that the ...